• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名无症状女孩患III型酪氨酸血症。

Tyrosinemia type III in an asymptomatic girl.

作者信息

Szymanska Edyta, Sredzinska Malgorzata, Ciara Elzbieta, Piekutowska-Abramczuk Dorota, Ploski Rafal, Rokicki Dariusz, Tylki-Szymanska Anna

机构信息

Department of Pediatrics, Nutrition and Metabolic Disorders, The Children's Memorial Health Institute, Warsaw, Poland.

Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.

出版信息

Mol Genet Metab Rep. 2015 Oct 22;5:48-50. doi: 10.1016/j.ymgmr.2015.10.004. eCollection 2015 Dec.

DOI:10.1016/j.ymgmr.2015.10.004
PMID:28649543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5471395/
Abstract

Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29-86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3.

摘要

3型酪氨酸血症(HT3)是一种罕见的酪氨酸代谢先天性缺陷病,由编码4-羟基苯丙酮酸双加氧酶的基因突变引起,呈常染色体隐性遗传。该病症的特征是体液中酪氨酸蓄积以及酪氨酸衍生物大量排泄到尿液中(www.orpha.net)。由于它是酪氨酸血症最不常见的形式,迄今为止仅报道了少数具有不同但相对较轻临床特征的病例。我们报告了一名11岁女孩,无临床症状,智力发育正常,通过代谢筛查被诊断为HT3,其血清酪氨酸水平升高至425至535μmol/L(正常值:29 - 86μmol/L),尿中对羟基苯衍生物排泄增加,经基因检测证实该基因存在纯合的c.479A > G(p.Tyr160Cys)错义突变。该女孩仅表现为病因不明的复发性蛋白尿。从未给予过苯丙氨酸和酪氨酸限制饮食。该病例提示,高酪氨酸浓度本身可能并不直接参与3型酪氨酸血症患者所描述的神经元损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353a/5471395/ff0c6a4e3cc4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353a/5471395/ff0c6a4e3cc4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/353a/5471395/ff0c6a4e3cc4/gr1.jpg

相似文献

1
Tyrosinemia type III in an asymptomatic girl.一名无症状女孩患III型酪氨酸血症。
Mol Genet Metab Rep. 2015 Oct 22;5:48-50. doi: 10.1016/j.ymgmr.2015.10.004. eCollection 2015 Dec.
2
Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.4-羟基苯丙酮酸双加氧酶基因突变是导致III型酪氨酸血症和霍金斯尿症的原因。
Mol Genet Metab. 2000 Nov;71(3):506-10. doi: 10.1006/mgme.2000.3085.
3
A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation.一例伴有癫痫持续状态和智力发育迟缓的III型酪氨酸血症病例。
Adv Biomed Res. 2018 Jan 22;7:7. doi: 10.4103/2277-9175.223740. eCollection 2018.
4
Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.III型酪氨酸血症患者4-羟基苯丙酮酸双加氧酶基因(HPD)的突变
Hum Genet. 2000 Jun;106(6):654-62. doi: 10.1007/s004390000307.
5
Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases.III型酪氨酸血症患者的新型头颅影像学表现及剪接位点变异,以及已发表病例总结
Mol Syndromol. 2022 May;13(3):193-199. doi: 10.1159/000519256. Epub 2022 Jan 4.
6
Increased nitric oxide release by neutrophils of a patient with tyrosinemia type III.III型酪氨酸血症患者中性粒细胞一氧化氮释放增加。
Biomed Pharmacother. 2009 Jun;63(5):359-61. doi: 10.1016/j.biopha.2008.06.030. Epub 2008 Jul 9.
7
The genetic tyrosinemias.遗传性酪氨酸血症
Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):121-6. doi: 10.1002/ajmg.c.30092.
8
Novel HPD mutation p.A244V compound with p.T219M causing tyrosinemia type III in a Chinese girl and review of the genotype-phenotype spectrum.新型 HPD 突变 p.A244V 复合突变 p.T219M 导致中国一女童患 III 型酪氨酸血症,并对基因型-表型谱进行综述。
Mol Genet Genomic Med. 2024 Jan;12(1):e2298. doi: 10.1002/mgg3.2298. Epub 2023 Oct 10.
9
Tyrosinemia Type III detected via neonatal screening: management and outcome.新生儿筛查发现的 III 型酪氨酸血症:治疗和结局。
Mol Genet Metab. 2012 Nov;107(3):605-7. doi: 10.1016/j.ymgme.2012.09.002. Epub 2012 Sep 7.
10
The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III).非肝性酪氨酸血症(类型 II、III)的突变谱和种族分布。
Orphanet J Rare Dis. 2022 Dec 5;17(1):424. doi: 10.1186/s13023-022-02579-0.

引用本文的文献

1
UK Dietary Practices for Tyrosinaemias: Time for Change.英国酪氨酸血症患者的饮食实践:是时候改变了。
Nutrients. 2022 Dec 7;14(24):5202. doi: 10.3390/nu14245202.
2
The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III).非肝性酪氨酸血症(类型 II、III)的突变谱和种族分布。
Orphanet J Rare Dis. 2022 Dec 5;17(1):424. doi: 10.1186/s13023-022-02579-0.
3
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.

本文引用的文献

1
Recommendations for the management of tyrosinaemia type 1.推荐 1 型酪氨酸血症的管理。
Orphanet J Rare Dis. 2013 Jan 11;8:8. doi: 10.1186/1750-1172-8-8.
2
Fumarylacetoacetate inhibits the initial step of the base excision repair pathway: implication for the pathogenesis of tyrosinemia type I.延胡索酸乙酰乙酸酯抑制碱基切除修复途径的初始步骤:对酪氨酸血症 I 发病机制的影响。
J Inherit Metab Dis. 2013 Sep;36(5):773-8. doi: 10.1007/s10545-012-9556-0. Epub 2012 Nov 9.
3
Tyrosinemia Type III detected via neonatal screening: management and outcome.
在使用尼替西农治疗的黑尿症患者中,比较角膜病变组与无角膜病变组以及不同性别之间的苯丙氨酸/酪氨酸途径及相关因素。
Metabolites. 2022 Aug 22;12(8):772. doi: 10.3390/metabo12080772.
4
Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases.III型酪氨酸血症患者的新型头颅影像学表现及剪接位点变异,以及已发表病例总结
Mol Syndromol. 2022 May;13(3):193-199. doi: 10.1159/000519256. Epub 2022 Jan 4.
5
TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW.三型酪氨酸血症:一份兄妹病例报告及文献复习。
Rev Paul Pediatr. 2020 Jun 5;38:e2018158. doi: 10.1590/1984-0462/2020/38/2018158. eCollection 2020.
6
HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage.TTC36-STK33-PELI1 信号轴调控 HPD 降解导致酪氨酸血症和神经损伤。
Nat Commun. 2019 Sep 19;10(1):4266. doi: 10.1038/s41467-019-12011-0.
7
Hawkinsinuria With Direct Hyperbilirubinemia in Egyptian-Lebanese Boy.一名埃及-黎巴嫩裔男孩患伴有直接胆红素血症的霍金斯尿症。
Front Pediatr. 2019 Mar 29;7:69. doi: 10.3389/fped.2019.00069. eCollection 2019.
8
An Introduction to Pharmacotherapy for Inborn Errors of Metabolism.先天性代谢缺陷的药物治疗导论
J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):432-446. doi: 10.5863/1551-6776-23.6.432.
9
All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.体内利用脑膜炎奈瑟菌 Cas9 实现腺相关病毒的递送和全基因组编辑。
Genome Biol. 2018 Sep 19;19(1):137. doi: 10.1186/s13059-018-1515-0.
新生儿筛查发现的 III 型酪氨酸血症:治疗和结局。
Mol Genet Metab. 2012 Nov;107(3):605-7. doi: 10.1016/j.ymgme.2012.09.002. Epub 2012 Sep 7.
4
Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats.酪氨酸会损害大鼠大脑皮层的能量代谢酶。
Mol Cell Biochem. 2012 May;364(1-2):253-61. doi: 10.1007/s11010-012-1225-y. Epub 2012 Feb 5.
5
Increased nitric oxide release by neutrophils of a patient with tyrosinemia type III.III型酪氨酸血症患者中性粒细胞一氧化氮释放增加。
Biomed Pharmacother. 2009 Jun;63(5):359-61. doi: 10.1016/j.biopha.2008.06.030. Epub 2008 Jul 9.
6
The genetic tyrosinemias.遗传性酪氨酸血症
Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):121-6. doi: 10.1002/ajmg.c.30092.
7
4-Hydroxyphenylpyruvate dioxygenase.4-羟基苯丙酮酸双加氧酶
Arch Biochem Biophys. 2005 Jan 1;433(1):117-28. doi: 10.1016/j.abb.2004.08.015.
8
Outcome of tyrosinaemia type III.III型酪氨酸血症的结局
J Inherit Metab Dis. 2001 Dec;24(8):824-32. doi: 10.1023/a:1013936107064.
9
Tyrosinemia: a review.酪氨酸血症:综述
Pediatr Dev Pathol. 2001 May-Jun;4(3):212-21. doi: 10.1007/s100240010146.
10
Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.III型酪氨酸血症患者4-羟基苯丙酮酸双加氧酶基因(HPD)的突变
Hum Genet. 2000 Jun;106(6):654-62. doi: 10.1007/s004390000307.